Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baofeikang Granule in Combined Pulmonary Fibrosis and Emphysema
NCT02805699Phase 2Unknown
- Start
- Jun 2016
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Baofeikang in combined pulmonary fibrosis and emphysema (CPFE). Status: unknown.
02
Drugs
Baofeikang
03
Conditions
combined pulmonary fibrosis and emphysema (CPFE)
Beyond the preview
Go deeper on NCT02805699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02805699.